Consensus Amgen Inc.

Stocks

AMGN

US0311621009

Pharmaceuticals

Real-time Estimate Cboe BZX 20:16:51 11/11/2026 GMT			5-day change	1st Jan Change
466.65 ^USD	+0.31%		-2.53%	+42.49%

02:00pm	Amgen's Sjogren's drug cuts disease activity in trial	RE
01:56pm	Amgen Potential Autoimmune Drug Meets Primary Endpoint in Late-Stage Study	MT

Evolution of the Average Target: Amgen Inc.

Evolution of the Target Price: Amgen Inc.

Changes in Analyst Recommendations: Amgen Inc.

6b636c73b6b418c5703.UiV8-o3WXX7FeQgyVAcyI6hHWT2TzynK6P_7SmVHoAI.OHcYvt-MCAyXQGEfHWtkQOVwbgn2-Rmfg8-te1cf8zUTEC-CwYUpKocjQQ~6b3bb2f7d3a78aaa7df9e84f8aeaf002

Analysts' recommendations: Amgen Inc.

10:57am	Daiwa Securities Adjusts Price Target on Amgen to $490 From $430	MT
11-05	Guggenheim Adjusts Price Target on Amgen to $435 From $378	MT
11-04	Amgen's Diversified Base Business Warrants Higher Multiple, UBS Says	MT
11-04	Amgen's Better-Than-Expected Q3 Results, Guidance Upgrade Support Bullish Outlook, Oppenheimer Says	MT
11-04	Scotiabank Adjusts Price Target on Amgen to $530 From $500	MT
11-04	BofA Securities Adjusts Price Target on Amgen to $347 From $328	MT
11-04	Morgan Stanley Adjusts Price Target on Amgen to $410 From $359	MT
11-04	Truist Adjusts Price Target on Amgen to $398 From $380	MT
11-04	Wells Fargo Adjusts Price Target on Amgen to $460 From $430	MT
11-04	Oppenheimer Adjusts Amgen Price Target to $520 From $480	MT
11-04	TD Cowen Adjusts Price Target on Amgen to $531 From $452	MT
11-04	Goldman Sachs Adjusts Price Target on Amgen to $536 From $481	MT
11-04	BMO Capital Adjusts Price Target on Amgen to $442 From $415	MT
11-04	JPMorgan Adjusts Price Target on Amgen to $425 From $350	MT
11-04	UBS Adjusts Price Target on Amgen to $530 From $470	MT
11-04	Canaccord Genuity Adjusts Price Target on Amgen to $440 From $384	MT
11-04	Bernstein Adjusts Price Target on Amgen to $400 From $345	MT
11-04	RBC Capital Adjusts Price Target on Amgen to $470 From $430	MT
11-04	Analyst recommendations: Adobe, AMD, Duolingo, Fortinet, Apple…
11-04	Citigroup Adjusts Price Target on Amgen to $465 From $405	MT
11-02	Wall Street Picks Up the Pieces
10-26	A Week of Reckoning for Wall Street
10-26	Jefferies Adjusts Price Target on Amgen to $428 From $410	MT
10-23	Amgen's Growth Drivers, Pipeline Could Support Longer-Term Outlook, Oppenheimer Says	MT
10-23	Oppenheimer Adjusts Amgen Price Target to $480 From $450, Maintains Outperform Rating	MT

More recommendations

Other Pharmaceuticals

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	AMGEN INC.					-7.63%
	ELI LILLY AND COMPANY					+1.47%
	JOHNSON & JOHNSON					-0.49%
	ABBVIE INC.					+5.7%
	ROCHE HOLDING AG					-1.34%
	MERCK & CO., INC.					+9.1%
	NOVARTIS AG					-5.5%
	ASTRAZENECA PLC					+16.05%
	GILEAD SCIENCES, INC.					+2.28%
	NOVO NORDISK A/S					+10.46%
	Average					+3.01%
	Weighted average by Cap.					+2.39%